Zydus Lifesciences Q2 profit rises 14% to ₹911 crore, topline surges 20%

The organic capex for the September quarter stood at nearly ₹302 crore, while it was ₹603 crore for the half year.

Leave a Reply

Your email address will not be published. Required fields are marked *